Product Information
LAMIVUDINE HBV 100 MG TABLET is a generic product labeled by Apotex Corp., priced at $9.9043 per EA under NDC 60505325006. Its NADAC has been published 615 times since Apr 23, 2014.
FDA first approved this application on Jan 2, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Apotex Corp.NDC
60505325006
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA202941FDA Approved
1/2/2014
TE Code
AB
On Market Since
1/3/2014
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE HBV 100 MG TABLET has been published 615 times since Apr 23, 2014, and over the history we have for it it has declined 7.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.9043 per EA |
|---|---|
| All-time high | $11.2082 (Nov 12, 2014) |
| All-time low | $1.5548 (May 17, 2023) |
| 52-week high | $10.0366 |
| 52-week low | $8.6264 |
| Median price | $4.5803 |
| Average price | $5.4049 |
| Largest weekly change | +160.1% (Sep 18, 2024) |
| Weeks tracked | 615 |
| Tracking since | Apr 23, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LAMIVUDINE HBV 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE HBV 100 MG TABLET, manufactured by Apotex Corp., is $9.9043 per EA (NDC 60505325006), effective Aug 19, 2026.
How has the price of LAMIVUDINE HBV 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE HBV 100 MG TABLET has declined 7.6%. It has been tracked across 615 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE HBV 100 MG TABLET?
Since Apr 23, 2014, the NADAC for LAMIVUDINE HBV 100 MG TABLET has ranged from a low of $1.5548 (May 17, 2023) to a high of $11.2082 (Nov 12, 2014), with a median of $4.5803 per EA.
Are there cheaper alternatives to LAMIVUDINE HBV 100 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMIVUDINE HBV 100 MG TABLET, is $8.1597 per EA — about 18% below LAMIVUDINE HBV 100 MG TABLET.
Who manufactures LAMIVUDINE HBV 100 MG TABLET?
LAMIVUDINE HBV 100 MG TABLET (NDC 60505325006) is labeled by Apotex Corp., and CMS classifies it as a generic product.